"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness.*

This bill would establish a legal framework for supervised psilocybin therapy in New Jersey for adults 21+ with behavioral health conditions. It creates licensed psilocybin service centers where trained facilitators provide guided sessions, requiring prior medical referrals and mandatory preparation/integration therapy sessions with mental health providers. The bill defines key terms like "administration session" and "adverse event," and mandates a regulatory system including a Psilocybin Advisory Board to oversee safety, prevent diversion, and ensure accessibility. It specifically targets conditions like depression, anxiety, and treatment-resistant depression, with provisions to develop a statewide strategic plan for long-term service delivery. The bill does not legalize recreational use but focuses on regulated medical access under strict supervision.